Sort   by:  
 Page size 
UnknownADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's Disease.
Not available
S-EPMC4972530 | biostudies-literature
UnknownDown-regulation of the met receptor tyrosine kinase by presenilin-dependent regulated intramembrane proteolysis.
Not available
S-EPMC2675628 | biostudies-literature
UnknownRecording and classifying MET receptor mutations in cancers.
Not available
S-EPMC11042802 | biostudies-literature
UnknownProteolytic cleavages of MET: the divide-and-conquer strategy of a receptor tyrosine kinase.
Not available
S-EPMC6507848 | biostudies-literature
UnknownPEA3 transcription factors are downstream effectors of Met signaling involved in migration and invasiveness of Met-addicted tumor cells.
Not available
S-EPMC5528715 | biostudies-literature
UnknownOrai3 calcium channel and resistance to chemotherapy in breast cancer cells: the p53 connection.
Not available
S-EPMC5864197 | biostudies-literature
UnknownCaspases shutdown nonsense-mediated mRNA decay during apoptosis.
Not available
S-EPMC4648321 | biostudies-literature
UnknownComprehensive map of the regulatory network triggered by MET exon 14 skipping reveals important involvement of the RAS-ERK signaling pathway.
Not available
S-EPMC12583649 | biostudies-literature
UnknownOptimized approach for the identification of highly efficient correctors of nonsense mutations in human diseases.
Not available
S-EPMC5683606 | biostudies-literature
UnknownTensin-4-dependent MET stabilization is essential for survival and proliferation in carcinoma cells.
Not available
S-EPMC4118019 | biostudies-literature
Sort   by:  
 Page size